Senior Citizen Held For Trying To Smuggle Tramadol To US

Mumbai : The Airport Special Cargo Commissionerate of the Customs department arrested a 62-year-old man for allegedly trying to export tramadol tablets to the US. The agency officials had previously seized a consignment of 848 strips of tramadol.

According to Customs sources, on June 6, an export consignment of foreign post was examined when the officials got suspicious during its screening. The screening of consignment resulted in the recovery of 848 strips with each strip of 10 tablets of tramadol hydrochloride tablets ol-tram tablets 100mg. The cost of seized tablets is around Rs 5 lakh.

“Tramadol was declared as apsychotropic substance and its small and commercial quantity were notified in a gazette notification dated April 26, 2018, therefore, its manufacture, possession, transportation, import and export inter-state, sale, purchase, use, consumption, storage, distribution, disposal or acquisition of is prohibited under Section 8(c) of the Narcotic Drugs & Psychotropic Substances Act. It is a scheduled ‘H’ and can only be dispensed on the prescription of a registered medical practitioner,” said a Custom officer.

A source, privy to the investigation stated that the man was apprehended from Kurla and was subsequently arrested for attempt to export tramadol. “We are probing from where he procured tramadol and who was supposed to receive it. We are also probing if the accused had been involved in the illegal export of tramadol in the past,” the official said.

According to a UN report, tramadol tablets are widely used by terrorist organisations,including Boko Haram inWest and Central Africa as a pain killer to boostfighting skills and is mostly imported from South Asia.

  • Related Posts

    • Pharma
    • June 24, 2025
    • 91 views
    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

    • Pharma
    • June 24, 2025
    • 93 views
    India’s herbal and ayurvedic OTC market set to outpace global growth

    New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India

    India’s herbal and ayurvedic OTC market set to outpace global growth

    India’s herbal and ayurvedic OTC market set to outpace global growth

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug